Zosano Pharma (ZSAN) IPO Opens Higher
Get Alerts ZSAN Hot Sheet
Join SI Premium – FREE
Today's IPO for Zosano Pharma Corporation (Nasdaq: ZSAN) opened for trading at $11.66 after pricing 4,500,000 shares of common stock at a price to the public of $11.00 per share.
Ladenburg Thalmann and Roth Capital Partners are acting as joint book-running managers.
Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications. Zosano's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano's microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boundless Bio (BOLD) Prices 6.25M Share IPO at $16/sh
- GDS Holdings Limited (GDS) Announces $587M Equity Raise For its International Business
- Wellchange Holdings Company (WCT) Announces 2M Share IPO at $4-$5/sh
Create E-mail Alert Related Categories
IPOsRelated Entities
Roth Capital, Ladenburg Thalmann Financial Services, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!